Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
Marco H Ji,1 Natalia F Callaway,1 Margaret A Greven,2 Daniel Vail,1 Darius M Moshfeghi1 1Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; 2Department of Ophthalmology, Wake Forest University School...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-04-01
|
| Series: | Clinical Ophthalmology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/telemedicine-follow-up-for-intravitreal-bevacizumab-injection-in-the-s-peer-reviewed-article-OPTH |
| _version_ | 1831707600646832128 |
|---|---|
| author | Ji MH Callaway NF Greven MA Vail D Moshfeghi DM |
| author_facet | Ji MH Callaway NF Greven MA Vail D Moshfeghi DM |
| author_sort | Ji MH |
| collection | DOAJ |
| description | Marco H Ji,1 Natalia F Callaway,1 Margaret A Greven,2 Daniel Vail,1 Darius M Moshfeghi1 1Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; 2Department of Ophthalmology, Wake Forest University School of Medicine, Winston-Salem, North CarolinaCorrespondence: Darius M Moshfeghi Tel +1 (650) 723-6995Email dariusm@stanford.eduAbstract: Telemedicine has emerged as a potential solution to face the disproportion between infants that need to be screened for retinopathy of prematurity (ROP) and the lack of ophthalmologists. We evaluated its utility in the follow-up after off-label intravitreal injection of bevacizumab. None of the treated infants ended up with bad anatomic outcome. Telemedicine is an alternative safe method to monitor patients after treatment.Keywords: pediatric retina, retina, pediatric ophthalmology |
| first_indexed | 2024-12-20T21:42:47Z |
| format | Article |
| id | doaj.art-c80a5fc3eb0e413aa81e8dab410cd517 |
| institution | Directory Open Access Journal |
| issn | 1177-5483 |
| language | English |
| last_indexed | 2024-12-20T21:42:47Z |
| publishDate | 2020-04-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Clinical Ophthalmology |
| spelling | doaj.art-c80a5fc3eb0e413aa81e8dab410cd5172022-12-21T19:25:45ZengDove Medical PressClinical Ophthalmology1177-54832020-04-01Volume 141161116353419Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) CohortJi MHCallaway NFGreven MAVail DMoshfeghi DMMarco H Ji,1 Natalia F Callaway,1 Margaret A Greven,2 Daniel Vail,1 Darius M Moshfeghi1 1Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; 2Department of Ophthalmology, Wake Forest University School of Medicine, Winston-Salem, North CarolinaCorrespondence: Darius M Moshfeghi Tel +1 (650) 723-6995Email dariusm@stanford.eduAbstract: Telemedicine has emerged as a potential solution to face the disproportion between infants that need to be screened for retinopathy of prematurity (ROP) and the lack of ophthalmologists. We evaluated its utility in the follow-up after off-label intravitreal injection of bevacizumab. None of the treated infants ended up with bad anatomic outcome. Telemedicine is an alternative safe method to monitor patients after treatment.Keywords: pediatric retina, retina, pediatric ophthalmologyhttps://www.dovepress.com/telemedicine-follow-up-for-intravitreal-bevacizumab-injection-in-the-s-peer-reviewed-article-OPTHpediatric retinaretinapediatric ophthalmology |
| spellingShingle | Ji MH Callaway NF Greven MA Vail D Moshfeghi DM Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort Clinical Ophthalmology pediatric retina retina pediatric ophthalmology |
| title | Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort |
| title_full | Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort |
| title_fullStr | Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort |
| title_full_unstemmed | Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort |
| title_short | Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort |
| title_sort | telemedicine follow up for intravitreal bevacizumab injection in the stanford university network for diagnosis of retinopathy of prematurity sundrop cohort |
| topic | pediatric retina retina pediatric ophthalmology |
| url | https://www.dovepress.com/telemedicine-follow-up-for-intravitreal-bevacizumab-injection-in-the-s-peer-reviewed-article-OPTH |
| work_keys_str_mv | AT jimh telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort AT callawaynf telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort AT grevenma telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort AT vaild telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort AT moshfeghidm telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort |